Trial Profile
An Evaluation of Efficacy and Safety of Corresponding Doses of Pulmicort Turbuhaler and Pulmicort Respules in Japanese Asthmatic Adult Patients (Open, Multicenter, Phase III Study).
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Nov 2018
Price :
$35
*
At a glance
- Drugs Budesonide (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 04 May 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 04 May 2010 Actual patient number (113) added as reported by ClinicalTrials.gov.
- 04 May 2010 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.